The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

April 2020

Volume 15 Number 17

This edition features articles on the incidence of major infections in PCI or CABG in the randomized SYNTAX trial; the PEPCAD NSTEMI trial randomising NSTEMI patients to drug-coated balloon or stents; a study of LAAO vs non-vitamin K antagonist oral anticoagulants; a look at the question of whether and when a patient is too old for TAVI; and the results of the TRICAVAL trial for severe tricuspid regurgitation comparing the implantation of a balloon-expandable transcatheter valve into the inferior vena cava (CAVI) vs medical therapy.

Highlights from this issue

TAVI in nonagenarians
TAVI in nonagenarians
Deharo P, Bisson A, Herbert J, Lacour T, Saint Etienne C, Theron A, Porto A, Collart F, Bourguignon T, Cuisset T, Fauchier L
April 17, 2020
DOI: 10.4244/EIJ-D-19-00647
PEPCAD NSTEMI
PEPCAD NSTEMI
Scheller B, Ohlow M, Ewen S, Kische S, Rudolph T, Clever Y, Wagner A, Richter S, El-Garhy M, Böhm M, Degenhardt R, Mahfoud F, Lauer B
April 17, 2020
DOI: 10.4244/EIJ-D-19-00723

Interventions for valvular disease and heart failure